Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.
about
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategyNickel oxide nanoparticles can recruit eosinophils in the lungs of rats by the direct release of intracellular eotaxinDoxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy.Nanomedicinal products: a survey on specific toxicity and side effects.Analysis of Complement Activation by Nanoparticles.Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum.Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations.Inner ear barriers to nanomedicine-augmented drug delivery and imaging.Main trends of immune effects triggered by nanomedicines in preclinical studiesA New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer TherapyInvolvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization
P2860
Q28081577-D86A0423-F6B8-4603-801E-7CE34CF99DA6Q28396488-E256EABB-EBC4-4DC9-A3B2-1B170D8633BCQ33553585-4230B6C6-FC5F-4D8D-B89A-3E17895CF84BQ41545896-5C350698-4ABB-4315-887D-2187CB003008Q47642394-0E925980-85E8-44CC-BB7C-22DFED0421B4Q48182671-F7D38DD0-AE3C-4FCD-B4BC-80CADABEEBA1Q48365025-0F652B7E-BFA0-4C24-A7D9-877E06DF8B9AQ55364353-A61EEC76-DB72-4F84-B7AF-6FED684F4AD3Q57074417-075CA2B7-AEAC-4E06-B949-B59707EEA969Q57491566-CF4A8665-6257-43BE-90E1-A012B09091D1Q57815916-FD6F9F81-D6B1-4B20-9E64-8F10DA9DCF19
P2860
Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Complement activation as a bio ...... d other nanoparticulate drugs.
@en
type
label
Complement activation as a bio ...... d other nanoparticulate drugs.
@en
prefLabel
Complement activation as a bio ...... d other nanoparticulate drugs.
@en
P1476
Complement activation as a bio ...... d other nanoparticulate drugs.
@en
P2093
Gert Storm
Janos Szebeni
P304
P356
10.1016/J.BBRC.2015.06.177
P407
P577
2015-07-13T00:00:00Z